- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Gillian Woollett Highlights International Markets With Successful Biosimilar Adoption
Gillian Woollett, MA, Dphil, vice president and head of regulatory strategy and policy at Samsung Bioepis, gives insight into what international markets the United States could look to as examples of good biosimilar adoption.
Gillian Woollett, MA, Dphil, vice president and head of regulatory strategy and policy at Samsung Bioepis, gives insight into what international markets the United States could look to as examples of good biosimilar adoption at the Festival of Biologics 2022 meeting in San Diego, California.
Transcript
Besides Europe, what other markets should the US look to as examples of good biosimilar adoption?
Well, Canada came up a little bit on the adoption because they've been most proactive on ideas around switching. So, the issues on switching of patients, whether they're on the originator or on another biosimilar, were discussed, and I don't think anybody really had a basis for clinical concerns given all the data that's accruing. But there's definitely an expectation that switching from [the] reference to biosimilar is somehow different than between biosimilars even though all of them would be under the auspices of a physician's prescription given that, basically, we haven't had [much experience with] interchangeables yet, at any level, even in the United States, and we don't have interchangeables anywhere else in the world. There was actually a presentation from Denmark that also gave a lot of their experience. So, that's useful; they've been actively switching.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
